Aisar-PDD

AISAR-PDD is proud to offer a broad range of in-vitro, in-vivo, and ex-vivo biochemical and pharmacological cell-based assays and animal models relevant to several disorders with immuno-inflammatory underlying cause and cancer diseases. These models have been refined and performed by internationally known scientists to bridge critical gaps in the pharmaceutical and biotechnology industry in testing the efficacy and optimization of new active molecules. The process to bring a new drug to market today is daunting and expensive, and small flexible research partners such as AISAR-PDD are becoming an industry necessity. Operating under a virtual business model we offer:

Quality and innovation through customization of niche experiments

Scientist to scientist communication

Flexibility and reliability: adjusting protocols as necessary

Reduction in development time

Efficiency: reporting progress and results in a timely manner in industry standards compliant format

Cost reduction: our low overhead cost allows us to accomodate the budget of your study.